ONCOGENES IN HUMAN CANCER INDUCTION
ONCOGENES IN HUMAN CANCER INDUCTION
批准号:
2091764
负责人:
Esther H Chang
金额:
$13.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-01 至 1995-01-09
中文摘要
家族性癌症综合征提供了一个独特的机会来检查
英文摘要
Familial cancer syndromes provide a unique opportunity to examine the
mechanism of inherited susceptibility to cancer, as well as the more
general processes involved in the development of malignancy. Our
laboratory is studying a family with Li-Fraumeni syndrome, which is
characterized by the development of diverse neoplasms as multiple primary
tumors within single individuals. Particular emphasis has been placed on
the role of oncogenes in the development of these tumors. Oncogenes are
genes involved in the development of malignancy. Oncogenes derive from
normal cellular genes, termed proto-oncogenes, when the latter are altered
by point mutation, deletion, rearrangement, or amplification. Evidence for
the involvement of oncogenes in non-inherited human malignancy, as well as
in inherited predisposition to cancer, continues to accumulate. The normal
functions of several proto-oncogenes have been elucidated; they are
involved in normal cell growth, division, metabolism, and/or
differentiation. Proto-oncogene products functions as growth factors or
growth factor receptors, tyrosine-specific or serine/threonine-specific
protein kinases, G-proteins exhibiting GTPase activities, or nuclear
proteins participating in DNA synthesis.
In this application, we propose to study the involvement of
proto-oncogene(s), oncogene(s), and suppressor genes in the predisposition
of the members of a cancer-prone family. Our goal is to identify and
characterize the primary genetic defect shared in this family; however, in
this process, we may have uncovered certain oncogenes which may represent
secondary and tertiary genetic defects. We will (1) continue to analyse
two transforming genes derived from the normal skin fibroblasts of two
affected family members, the proband, and his brother, (2) attempt to
identify the transforming gene(s) in normal skin fibroblasts of other
family members, and (3) assess the possible involvement of a suppressor
gene, Rb, in the family genetic defect. The oncogene will be molecularly
cloned and compared to their normal counterparts. The genetic defect will
be defined by DNA sequence analysis and site-directed mutagenesis.
Specific antibodies will be raised to synthetic peptides and the
biosynthesis and subcellular localization of the oncogene product will be
examined. Attempts will be made to characterize the oncogene product and
to explore its function. RNA profile of the Rb gene in normal skin
fibroblasts of the family members will be examined by Northern analysis.
Rb DNA RFLPs will be detected by Southern hybridization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Targeted Nanomedicine Delivering MicroRNA-30-5p Replacement Therapy for Multi-drug Resistant Cancer Treatment
-
批准号:9409281
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2017
-
负责人:Esther H Chang
-
依托单位:
Nanoimmunoliposome-Complexed SPIO: Tumor-Specific Detection of Early Lung Cancer
-
批准号:7363424
-
项目类别:
-
资助金额:$61.46万
-
财政年份:2008
-
负责人:Esther H Chang
-
依托单位:
Nanoimmunoliposome-Complexed SPIO: Tumor-Specific Detection of Early Lung Cancer
-
批准号:7546974
-
项目类别:
-
资助金额:$63.32万
-
财政年份:2008
-
负责人:Esther H Chang
-
依托单位:
Nanoimmunoliposome-Complexed SPIO: Tumor-Specific Detection of Early Lung Cancer
-
批准号:7750581
-
项目类别:
-
资助金额:$63.06万
-
财政年份:2008
-
负责人:Esther H Chang
-
依托单位:
A Tumor-Specific Nanoimmunocomplex Markedly Improves MR Imaging
-
批准号:7107574
-
项目类别:
-
资助金额:$47.89万
-
财政年份:2006
-
负责人:Esther H Chang
-
依托单位:
Enhancement of Tumor-Targeted Transgene Expression
-
批准号:6736018
-
项目类别:
-
资助金额:$20.17万
-
财政年份:2004
-
负责人:Esther H Chang
-
依托单位:
A Dual Molecular/Tumor Targeting Therapy for PanCa
-
批准号:6833365
-
项目类别:
-
资助金额:$57.14万
-
财政年份:2003
-
负责人:Esther H Chang
-
依托单位:
A Dual Molecular/Tumor Targeting Therapy for PanCa
-
批准号:6951108
-
项目类别:
-
资助金额:$58.83万
-
财政年份:2003
-
负责人:Esther H Chang
-
依托单位:
A Dual Molecular/Targeting Therapy for PanCa
-
批准号:6695065
-
项目类别:
-
资助金额:$15.9万
-
财政年份:2003
-
负责人:Esther H Chang
-
依托单位:
Targeting Stealth Liposome for Cancer Gene Therapy
-
批准号:6444919
-
项目类别:
-
资助金额:$13.88万
-
财政年份:2002
-
负责人:Esther H Chang
-
依托单位:
A NOVEL IMPROVEMENT ON RADIOTHERAPY FOR SCCHN
-
批准号:6175895
-
项目类别:
-
资助金额:$41.63万
-
财政年份:1999
-
负责人:Esther H Chang
-
依托单位:
A NOVEL IMPROVEMENT ON RADIOTHERAPY FOR SCCHN
-
批准号:6523872
-
项目类别:
-
资助金额:$59.17万
-
财政年份:1999
-
负责人:Esther H Chang
-
依托单位:
Immunoliposome-Mediated Gene Therapy for Prostate Cancer
-
批准号:6444304
-
项目类别:
-
资助金额:$31.73万
-
财政年份:1999
-
负责人:Esther H Chang
-
依托单位:
A NOVEL IMPROVEMENT ON RADIOTHERAPY FOR SCCHN
-
批准号:6379918
-
项目类别:
-
资助金额:$57.57万
-
财政年份:1999
-
负责人:Esther H Chang
-
依托单位:
A NOVEL IMPROVEMENT ON RADIOTHERAPY FOR SCCHN
-
批准号:2825505
-
项目类别:
-
资助金额:$42.55万
-
财政年份:1999
-
负责人:Esther H Chang
-
依托单位:
Immunoliposome-Mediated Gene Therapy for Prostate Cancer
-
批准号:6668686
-
项目类别:
-
资助金额:$31.73万
-
财政年份:1999
-
负责人:Esther H Chang
-
依托单位:
IMMUNOLIPOSOME MEDIATED GENE THERAPY FOR PROSTATE CANCER
-
批准号:2777544
-
项目类别:
-
资助金额:$13.86万
-
财政年份:1999
-
负责人:Esther H Chang
-
依托单位:
SMALL INSTRUMENTATION PROGRAM
-
批准号:3522771
-
项目类别:
-
资助金额:$1.12万
-
财政年份:1988
-
负责人:Esther H Chang
-
依托单位:
ONCOGENES IN HUMAN CANCER INDUCTION
-
批准号:3188192
-
项目类别:
-
资助金额:$3.11万
-
财政年份:1986
-
负责人:Esther H Chang
-
依托单位:
STATUS OF P53 IN A LFS CANCER PRONE FAMILY
-
批准号:2693700
-
项目类别:
-
资助金额:$6.83万
-
财政年份:1986
-
负责人:Esther H Chang
-
依托单位:
海外基金